An ATP-competitive inhibitor of mTOR (IC50 = 0.19 nM) that inhibits signaling through both mTORC1 and mTORC2; effective in diverse cancer models, both in vitro and in vivo, blocking mTOR signaling and preventing growth in breast, lung, renal, and glioma cancer cells and tumor xenografts in mice.